Re: Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Zhou Q, Ma H. Eur Urol 2026 Apr 8:S0302-2838(26)02047-6. doi: 10.1016/j.eururo.2026.

Read + Share

Amedeo Smart

Independent Medical Education

Zhou Q, Ma H. Re: Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Eur Urol 2026 Apr 8:S0302-2838(26)02047-6. doi: 10.1016/j.eururo.2026.
PMID: 41956862